Peptinovo Biopharma

Ann Arbor, United States

Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.

$1.3M raised

Sep 2024

Venture - Series Unknown

Biopharma Biotechnology Therapeutics

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Peptinovo Biopharma

How much funding has Peptinovo Biopharma raised?

Peptinovo Biopharma has raised $1.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.

Where is Peptinovo Biopharma headquartered?

Peptinovo Biopharma is headquartered in Ann Arbor, United States.

What does Peptinovo Biopharma do?

Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.

What stage is Peptinovo Biopharma at?

Peptinovo Biopharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 24, 2024.

MLA

"Peptinovo Biopharma — Funding & Investors." VCBacked, September 24, 2024, https://www.vcbacked.co/company/peptinovo-biopharma. Accessed June 4, 2026.

APA

VCBacked. (2024). Peptinovo Biopharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/peptinovo-biopharma

Wikipedia (cite web)

{{cite web |title=Peptinovo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/peptinovo-biopharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 24, 2024.